Cargando…

Can urinary CTX-II be a biomarker for knee osteoarthritis?

BACKGROUND: Early diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge. Urinary C-terminal cross-linked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers. However, conclusive evidence regarding the use of this biomarker as a tool for early diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Arunrukthavon, Piti, Heebthamai, Danai, Benchasiriluck, Prapasri, Chaluay, Supinda, Chotanaphuti, Thanainit, Khuangsirikul, Saradej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796402/
https://www.ncbi.nlm.nih.gov/pubmed/35236476
http://dx.doi.org/10.1186/s42836-020-0024-2
_version_ 1784641309104930816
author Arunrukthavon, Piti
Heebthamai, Danai
Benchasiriluck, Prapasri
Chaluay, Supinda
Chotanaphuti, Thanainit
Khuangsirikul, Saradej
author_facet Arunrukthavon, Piti
Heebthamai, Danai
Benchasiriluck, Prapasri
Chaluay, Supinda
Chotanaphuti, Thanainit
Khuangsirikul, Saradej
author_sort Arunrukthavon, Piti
collection PubMed
description BACKGROUND: Early diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge. Urinary C-terminal cross-linked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers. However, conclusive evidence regarding the use of this biomarker as a tool for early diagnosis is still lacking. The purposes of this study were to compare urinary CTX-II levels in patients with knee OA and in healthy controls, to evaluate the correlation between urinary CTX-II levels, radiographic severity of OA, and patient-reported outcomes and to evaluate the effect of age and gender on urinary CTX-II levels in the Asian populations. METHODS: Two groups were studied. The OA group included 78 patients with knee OA aged > 40 years who met the diagnostic criteria for knee OA described by the American College of Rheumatology (ACR). The control group consisted of 51 healthy participants age > 40 years without clinical or radiographic evidence of knee OA. Bilateral knee radiographs were taken and classified according to the Kellgren and Lawrence (KL) grading system. Urinary CTX-II was measured using a competitive ELISA test and Western Ontario and Mcmaster Universities Arthritis Index (WOMAC) was also recorded in all participants. RESULTS: Urinary CTX-II was significantly higher in the OA group than in the control group (p < 0.001). The severe knee OA group (KL grade 3 and 4) had higher urinary CTX-II levels than mild knee OA group (KL grade 2) but the difference did not reach statistical significance (p = 0.2). There was a moderate correlation between urinary CTX-II levels and KL grades (r = 0.405, p < 0.001) and a weak correlation between urinary CTX-II levels and WOMAC index scores (r = 0.367, p < 0.001). Multiple regression analysis showed that urinary CTX-II was independently associated with KL grades. Whereas age, gender, and WOMAC index had no statistically significant influence on the urinary CTX-II levels. CONCLUSIONS: Patients with knee OA had higher urinary CTX-II levels than healthy controls. Moreover, levels of urinary CTX-II were independently correlated with radiographic severity of knee OA. Age, gender, and patient-reported outcomes exerted no effect on the urinary CTX-II levels. LEVEL OF EVIDENCE: Diagnostic Level III.
format Online
Article
Text
id pubmed-8796402
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87964022022-02-03 Can urinary CTX-II be a biomarker for knee osteoarthritis? Arunrukthavon, Piti Heebthamai, Danai Benchasiriluck, Prapasri Chaluay, Supinda Chotanaphuti, Thanainit Khuangsirikul, Saradej Arthroplasty Research BACKGROUND: Early diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge. Urinary C-terminal cross-linked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers. However, conclusive evidence regarding the use of this biomarker as a tool for early diagnosis is still lacking. The purposes of this study were to compare urinary CTX-II levels in patients with knee OA and in healthy controls, to evaluate the correlation between urinary CTX-II levels, radiographic severity of OA, and patient-reported outcomes and to evaluate the effect of age and gender on urinary CTX-II levels in the Asian populations. METHODS: Two groups were studied. The OA group included 78 patients with knee OA aged > 40 years who met the diagnostic criteria for knee OA described by the American College of Rheumatology (ACR). The control group consisted of 51 healthy participants age > 40 years without clinical or radiographic evidence of knee OA. Bilateral knee radiographs were taken and classified according to the Kellgren and Lawrence (KL) grading system. Urinary CTX-II was measured using a competitive ELISA test and Western Ontario and Mcmaster Universities Arthritis Index (WOMAC) was also recorded in all participants. RESULTS: Urinary CTX-II was significantly higher in the OA group than in the control group (p < 0.001). The severe knee OA group (KL grade 3 and 4) had higher urinary CTX-II levels than mild knee OA group (KL grade 2) but the difference did not reach statistical significance (p = 0.2). There was a moderate correlation between urinary CTX-II levels and KL grades (r = 0.405, p < 0.001) and a weak correlation between urinary CTX-II levels and WOMAC index scores (r = 0.367, p < 0.001). Multiple regression analysis showed that urinary CTX-II was independently associated with KL grades. Whereas age, gender, and WOMAC index had no statistically significant influence on the urinary CTX-II levels. CONCLUSIONS: Patients with knee OA had higher urinary CTX-II levels than healthy controls. Moreover, levels of urinary CTX-II were independently correlated with radiographic severity of knee OA. Age, gender, and patient-reported outcomes exerted no effect on the urinary CTX-II levels. LEVEL OF EVIDENCE: Diagnostic Level III. BioMed Central 2020-02-10 /pmc/articles/PMC8796402/ /pubmed/35236476 http://dx.doi.org/10.1186/s42836-020-0024-2 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Arunrukthavon, Piti
Heebthamai, Danai
Benchasiriluck, Prapasri
Chaluay, Supinda
Chotanaphuti, Thanainit
Khuangsirikul, Saradej
Can urinary CTX-II be a biomarker for knee osteoarthritis?
title Can urinary CTX-II be a biomarker for knee osteoarthritis?
title_full Can urinary CTX-II be a biomarker for knee osteoarthritis?
title_fullStr Can urinary CTX-II be a biomarker for knee osteoarthritis?
title_full_unstemmed Can urinary CTX-II be a biomarker for knee osteoarthritis?
title_short Can urinary CTX-II be a biomarker for knee osteoarthritis?
title_sort can urinary ctx-ii be a biomarker for knee osteoarthritis?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796402/
https://www.ncbi.nlm.nih.gov/pubmed/35236476
http://dx.doi.org/10.1186/s42836-020-0024-2
work_keys_str_mv AT arunrukthavonpiti canurinaryctxiibeabiomarkerforkneeosteoarthritis
AT heebthamaidanai canurinaryctxiibeabiomarkerforkneeosteoarthritis
AT benchasiriluckprapasri canurinaryctxiibeabiomarkerforkneeosteoarthritis
AT chaluaysupinda canurinaryctxiibeabiomarkerforkneeosteoarthritis
AT chotanaphutithanainit canurinaryctxiibeabiomarkerforkneeosteoarthritis
AT khuangsirikulsaradej canurinaryctxiibeabiomarkerforkneeosteoarthritis